News

Which Factors are Driving the Neurostimulation Devices Market in North America?

North America continues to dominate the global neurostimulation devices market, holding a significant 60% share in 2024. Several key factors… Read More

2 months ago

AAVnerGene and Klotho Neurosciences Join Forces to Revolutionize Gene Therapy

AAVnerGene Inc., an innovative biotech company based in Rockville, MD, known for its cutting-edge AAV tissue-targeted delivery and manufacturing technologies,… Read More

2 months ago

Hengrui and IDEAYA Biosciences to Present Breakthrough Data at IASLC 2025 World Conference on Lung Cancer

Jiangsu Hengrui Pharmaceuticals Co., Ltd. and IDEAYA Biosciences, Inc. are set to showcase their groundbreaking research at the IASLC 2025… Read More

2 months ago

QIAGEN Expands NGS Portfolio with Innovative Long-Read Panels

QIAGEN has launched its new QIAseq xHYB long-read panels, a cutting-edge solution designed to explore the complexities of genomically diverse… Read More

2 months ago

Kansai and Alloy Join Forces to Accelerate Japan’s Life Science Startup Ecosystem

Kyoto, Japan  July 2025  A groundbreaking collaboration has been formed between Kansai Startup Academia Coalition (KSAC), led by Kyoto University,… Read More

2 months ago

AI in Clinical Trials for Drugs Europe Breakthrough Moment

Europe is on the brink of a revolution in drug development, powered by Artificial Intelligence (AI). As healthcare systems strive… Read More

2 months ago

AusperBio Secures China CDE Approval to Advance AHB-137 into Phase 3 Clinical Trial for Chronic Hepatitis B

July 2025  Beijing, China: AusperBio Therapeutics Inc. and Ausper Biopharma Co., Ltd. (collectively known as AusperBio) have received the green… Read More

2 months ago

AstraZeneca Unveils $50 Billion Investment Plan to Supercharge U.S. Pharma Innovation by 2030

Virginia to host AstraZeneca’s largest-ever global manufacturing site, with AI-driven production and next-gen therapies July 2025 – USA: Global biopharma… Read More

2 months ago

Sarepta Therapeutics Temporarily Halts ELEVIDYS Shipments in U.S. Amid FDA Labeling Updates

Cambridge, MA  July 22, 2025: Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases, has voluntarily paused all… Read More

2 months ago

Cycle Pharmaceuticals and Handa Therapeutics Forge Strategic Partnership to Launch PHYRAGO for Leukemia Patients in the U.S.

In a major stride towards revolutionizing leukemia treatment in the U.S., Cycle Pharmaceuticals has signed an exclusive sales license agreement… Read More

2 months ago